New World Medical
Generated 5/9/2026
Executive Summary
New World Medical is a privately held ophthalmic medical device company founded in 1997 and headquartered in Rancho Cucamonga, California. The company specializes in developing and manufacturing innovative surgical devices for preserving and enhancing vision, with a primary focus on surgical glaucoma treatments. Its flagship product, the Kahook Dual Blade (KDB), is a minimally invasive glaucoma surgery (MIGS) device that has gained significant adoption among ophthalmic surgeons for its efficacy and safety. New World Medical is committed to expanding global access to eye care and has built a strong reputation for delivering high-quality, evidence-based solutions. The company operates in a competitive landscape but has carved out a niche with its differentiated technology and surgeon training programs.
Upcoming Catalysts (preview)
- Q3 2026FDA Clearance of Next-Generation Glaucoma Device60% success
- Q4 2026Expansion into Emerging Markets (e.g., China, India)70% success
- Q2 2026Positive Interim Results from Pivotal Clinical Trial55% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)